According to the latest data from the Hong Kong Stock Exchange, on July 14th, Norges Bank reduced its holding in Pharmaron (HKEX: 03759) by 1.34 million shares. The transaction was executed at an average price of approximately HK$22.86 per share, resulting in a total consideration of around HK$30.53 million.
Following this disposal, the bank's latest shareholding stands at approximately 24.43 million shares, representing a stake of 6.93% in the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments